Cargando…
Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer
Treatment of stage IV metastatic breast cancer patients is limited to palliative options and represents an unmet clinical need. Here, we demonstrate that pharmacological inhibition of miRNA-10b - a master regulator of metastatic cell viability – leads to elimination of distant metastases in a mouse...
Autores principales: | Yoo, Byunghee, Kavishwar, Amol, Wang, Ping, Ross, Alana, Pantazopoulos, Pamela, Dudley, Michael, Moore, Anna, Medarova, Zdravka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359550/ https://www.ncbi.nlm.nih.gov/pubmed/28322342 http://dx.doi.org/10.1038/srep45060 |
Ejemplares similares
-
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2021) -
Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer
por: Le Fur, Mariane, et al.
Publicado: (2021) -
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
por: Medarova, Zdravka, et al.
Publicado: (2020) -
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2019) -
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
por: Yoo, Byunghee, et al.
Publicado: (2019)